CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- 4 Planned sale Director sold 10,000 shares at $18.92 ($189,227)
- 4 Planned sale Watanabe Todd sold 10,129 shares at an average $17.54 ($177,628)
- 4 Planned sale Matsuda Masaru sold 36,130 shares at $16.16 ($583,716)
- 4 Planned sale Director sold 10,000 shares at $15.64 ($156,383)
- 4 Planned sale Burnett Patrick sold 4,188 shares at an average $15.82 ($66,250)
- 4 Planned sale Burnett Patrick sold 3,847 shares at $14.03 ($53,988)
- 4 Planned sale Watanabe Todd sold 11,547 shares at $14.33 ($165,429)
- 4 Planned sale Burnett Patrick sold 2,622 shares at $14.33 ($37,564)
- 4 Planned sale SVP Chief Financial Officer sold 89 shares at $14.33 ($1,275)
- 4 Planned sale Matsuda Masaru sold 6,330 shares at $14.33 ($90,687)
- 4 Planned sale Director sold 10,000 shares at $14.30 ($142,982)
- 4 Planned sale Burnett Patrick sold 28,750 shares at an average $15.05 ($432,700)
- 4 Planned sale Director sold 9,208 shares at $13.84 ($127,430)
- 4 Planned sale Director sold 10,139 shares at $13.37 ($135,574)
- 4 Open-market buy Director bought 2,646 shares at $13.08 ($34,610)
- 4 Grant or award Director acquired 7,609 shares (grant or award)
- 4 Grant or award Director acquired 7,609 shares (grant or award)
- 4 Grant or award Director acquired 7,609 shares (grant or award)
- 4 Grant or award Director acquired 7,609 shares (grant or award)
- 4 Grant or award Director acquired 7,609 shares (grant or award)
Page 5 of 23 · 452 filings